Is amitriptyline effective for treating monosymptomatic nocturnal enuresis in children and adolescents, and what dosing and safety precautions are recommended?

Amitriptyline for Enuresis

Amitriptyline is NOT a recommended treatment for monosymptomatic nocturnal enuresis in children—imipramine is the only tricyclic antidepressant with documented efficacy, and even then, it should only be used as third-line therapy at tertiary care facilities due to serious cardiotoxicity risks. 1

Treatment Hierarchy for Monosymptomatic Enuresis

First-Line Therapy

The evidence-based first-line treatments are:

• Enuresis alarm (most effective long-term)
• Desmopressin (0.2-0.4 mg tablets at bedtime)
• Basic bladder advice (though limited efficacy—only 18% success after 3 months) 1

Second-Line Therapy

If first-line treatments fail:

• Anticholinergics (oxybutynin 5 mg, tolterodine 2 mg, or propiverine 0.4 mg/kg at bedtime)
• Often combined with desmopressin
• Approximately 40% response rate 1

Third-Line Therapy: Tricyclic Antidepressants

Only imipramine has proven efficacy—not amitriptyline 1

When Imipramine May Be Considered:

• Alarm therapy has failed AND family cannot afford desmopressin
• At tertiary care facilities only
• Approximately 50% response rate, but 50% relapse rate 1

Imipramine Dosing:

• 25 mg at bedtime for children ≤9 years
• 50 mg at bedtime for children >9 years
• Evaluate after 1 month 1

Critical Safety Concerns with Tricyclics

Mandatory Precautions Before Imipramine:

1. Cardiac screening required: Obtain ECG to exclude long QT syndrome if ANY history of:

   • Palpitations or syncope in the child
   • Sudden cardiac death in family
   • Unstable arrhythmia in family 1

2. Fatal overdose risk: Drug must be kept locked and away from younger siblings—potentially cardiotoxic and lethal in overdose 1

3. Common side effects: Mood changes, nausea, insomnia (often appear before beneficial effects) 1

4. High tolerance risk: Require regular 2-week drug holidays every 3 months 1

Why Amitriptyline Is Not Recommended

While one small study 2 showed amitriptyline (25-50 mg) reduced wet nights from 5.8 to 3.3 per week, the International Children's Continence Society guidelines explicitly recommend only imipramine among tricyclics for enuresis 1. The FDA label for amitriptyline 3 does not include enuresis as an approved indication and carries a black box warning against pediatric use due to increased suicidality risk.

Evidence-Based Combination Therapy

If tricyclic therapy is pursued (imipramine only):

• Imipramine + oxybutynin is more effective than imipramine alone, with 48% failure rate versus 74% for monotherapy (RR 0.68) 4
• This combination showed sustained benefit at follow-up: 45% wetting versus 83% for imipramine alone 4

Comparative Effectiveness

Alarm therapy is superior to all tricyclics:

• 67% failure with imipramine versus only 17% with alarms (RR 4.00) 4
• More sustained effect: 100% relapse with imipramine versus 58% with alarms at follow-up 4

Common Pitfalls to Avoid

1. Never use amitriptyline—no guideline support, lacks pediatric approval for enuresis
2. Never use tricyclics as first-line—alarm and desmopressin are safer and more effective
3. Never prescribe imipramine without cardiac screening if any cardiac history exists
4. Never continue indefinitely—implement drug holidays to prevent tolerance
5. Expect relapse—96% of children relapse after stopping imipramine 4

The evidence is clear: start with alarm or desmopressin, escalate to anticholinergics if needed, and reserve imipramine (not amitriptyline) only for refractory cases at specialized centers 1.